Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study 2016.

ABSTRACT: Introduction:The global burden of disease (GBD) studies have derived detailed and comparable epidemiological and burden of disease estimates for schizophrenia. We report GBD 2016 estimates of schizophrenia prevalence and burden of disease with disaggregation by age, sex, year, and for all countries. Method:We conducted a systematic review to identify studies reporting the prevalence, incidence, remission, and/or excess mortality associated with schizophrenia. Reported estimates which met our inclusion criteria were entered into a Bayesian meta-regression tool used in GBD 2016 to derive prevalence for 20 age groups, 7 super-regions, 21 regions, and 195 countries and territories. Burden of disease estimates were derived for acute and residual states of schizophrenia by multiplying the age-,

SUBMITTER: Charlson FJ 

PROVIDER: S-EPMC6192504 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature